Trial Outcomes & Findings for Exploratory Subjective Sleep Study of a Prototype Nasal Dilator (NCT NCT01122849)

NCT ID: NCT01122849

Last Updated: 2018-04-09

Results Overview

The PIRS questionnaire had 3 sections (Section A \[Q1 to Q12\], Section B \[Q13 to 16\] and Section C \[Q17 to Q20\]). The following questions were asked from Section A : 1. One or more awakenings after getting to sleep and 3 Sleep that does not fully refresh you, and Section C: 17 Your sleep quality compared to most people and 18 Your satisfaction with your sleep. Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B, Q13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Q15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

Recruitment status

COMPLETED

Study phase

PHASE2

Target enrollment

61 participants

Primary outcome timeframe

At Baseline and Day 7

Results posted on

2018-04-09

Participant Flow

Participants were recruited at two centers in USA.

A total of 97 participants were screened for this study, out of which 61 participants were randomized to the study and 36 participants did not meet study criteria.

Participant milestones

Participant milestones
Measure
Marketed Nasal Strip
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Overall Study
STARTED
20
21
20
Overall Study
COMPLETED
20
21
20
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Exploratory Subjective Sleep Study of a Prototype Nasal Dilator

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=21 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=20 Participants
Participants applied the Prototype nasal dilator strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Total
n=61 Participants
Total of all reporting groups
Age, Customized
Years
46.1 Years
STANDARD_DEVIATION 10.17 • n=99 Participants
44.5 Years
STANDARD_DEVIATION 9.59 • n=107 Participants
42.5 Years
STANDARD_DEVIATION 13.97 • n=206 Participants
44.4 Years
STANDARD_DEVIATION 11.29 • n=7 Participants
Sex: Female, Male
Female
18 Participants
n=99 Participants
17 Participants
n=107 Participants
15 Participants
n=206 Participants
50 Participants
n=7 Participants
Sex: Female, Male
Male
2 Participants
n=99 Participants
4 Participants
n=107 Participants
5 Participants
n=206 Participants
11 Participants
n=7 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Race (NIH/OMB)
Asian
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Race (NIH/OMB)
Black or African American
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Race (NIH/OMB)
White
20 Participants
n=99 Participants
21 Participants
n=107 Participants
20 Participants
n=206 Participants
61 Participants
n=7 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
0 Participants
n=7 Participants

PRIMARY outcome

Timeframe: At Baseline and Day 7

Population: Analysis for this outcome was performed on intent-to-treat (ITT) population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

The PIRS questionnaire had 3 sections (Section A \[Q1 to Q12\], Section B \[Q13 to 16\] and Section C \[Q17 to Q20\]). The following questions were asked from Section A : 1. One or more awakenings after getting to sleep and 3 Sleep that does not fully refresh you, and Section C: 17 Your sleep quality compared to most people and 18 Your satisfaction with your sleep. Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B, Q13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Q15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q1
-0.911 Score on a scale
Interval -1.21 to -0.61
-0.694 Score on a scale
Interval -0.99 to -0.4
-1.032 Score on a scale
Interval -1.34 to -0.72
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q3
-1.004 Score on a scale
Interval -1.37 to -0.63
-0.708 Score on a scale
Interval -1.07 to -0.34
-0.947 Score on a scale
Interval -1.33 to -0.56
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q17
-0.721 Score on a scale
Interval -1.01 to -0.43
-0.349 Score on a scale
Interval -0.63 to -0.07
-0.539 Score on a scale
Interval -0.84 to -0.24
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 7
Q18
-0.643 Score on a scale
Interval -0.91 to -0.38
-0.234 Score on a scale
Interval -0.5 to 0.03
-0.697 Score on a scale
Interval -0.98 to -0.42

PRIMARY outcome

Timeframe: At Baseline and Day 14

Population: Analysis for this outcome was performed on intent-to-treat (ITT) population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participant were asked questions related to their sleep using PIRS questionnaire. The PIRS questionnaire had 3 sections. Section A (Q1 to Q12), Section B (Q13 to Q16) and Section C (Q17 to Q20). Section A question were scored as follows: 0= Not at all bothered, 1= slightly bothered, 2=moderately bothered, and 3= severely bothered. Section B questions 13 and 14 were scored as follows 0= Less than ½ hour, 1= between ½ to 1 hour, 2= between 1 to 3 hours and 3=more than 3 hours or I didn't sleep; Questions 15 and 16 were scored as 0=more than 7 hours, 1= between 4 to 7 hours, 2= between 2 to 4 hours, and 3=Less than 2 hours or I didn't sleep. Section C questions were scored as follows: 0=Excellent, 1=Good, 2=Fair, and 3=Poor. Lower PIRS score shows better sleep quality.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q18 (Your satisfaction with your sleep)
-0.873 Score on a scale
Interval -1.18 to -0.57
-0.464 Score on a scale
Interval -0.76 to -0.16
-0.951 Score on a scale
Interval -1.27 to -0.63
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q1 (One or more awakenings after getting to sleep)
-1.047 Score on a scale
Interval -1.36 to -0.74
-0.844 Score on a scale
Interval -1.14 to -0.54
-1.157 Score on a scale
Interval -1.48 to -0.84
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q3 (Sleep that does not fully refresh you)
-1.306 Score on a scale
Interval -1.69 to -0.92
-0.917 Score on a scale
Interval -1.3 to -0.54
-1.104 Score on a scale
Interval -1.5 to -0.7
Change From Baseline in Mean Average Score Using Pittsburgh Insomnia Rating Scale (PIRS) in Q1, Q3, Q17 and Q18 at Day 14
Q17 (Your sleep quality compared to most people)
-0.714 Score on a scale
Interval -1.04 to -0.39
-0.359 Score on a scale
Interval -0.68 to -0.04
-0.837 Score on a scale
Interval -1.17 to -0.5

PRIMARY outcome

Timeframe: At Baseline and Day 7

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers (such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Sleep Problems
-7.398 Score on a Scale
Interval -9.44 to -5.36
-4.194 Score on a Scale
Interval -6.18 to -2.21
-6.563 Score on a Scale
Interval -8.71 to -4.42
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Sleep time Problems
-7.494 Score on a Scale
Interval -9.99 to -5.0
-5.638 Score on a Scale
Interval -8.09 to -3.19
-8.212 Score on a Scale
Interval -10.81 to -5.61
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Symptoms on walking in the morning
-7.196 Score on a Scale
Interval -9.28 to -5.11
-4.074 Score on a Scale
Interval -6.13 to -2.02
-7.905 Score on a Scale
Interval -10.09 to -5.72
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7
Practical Problems
-2.774 Score on a Scale
Interval -4.02 to -1.52
-2.277 Score on a Scale
Interval -3.51 to -1.04
-3.079 Score on a Scale
Interval -4.38 to -1.78

PRIMARY outcome

Timeframe: At Baseline and Day 14

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Sleep Problems
-7.624 Score on a scale
Interval -9.68 to -5.57
-5.738 Score on a scale
Interval -7.74 to -3.74
-7.051 Score on a scale
Interval -9.21 to -4.89
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Sleep Time Problems
-8.746 Score on a scale
Interval -11.24 to -6.26
-7.051 Score on a scale
Interval -9.49 to -4.61
-6.768 Score on a scale
Interval -9.36 to -4.18
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Symptoms on waking in the morning
-7.858 Score on a scale
Interval -9.9 to -5.81
-5.318 Score on a scale
Interval -7.33 to -3.3
-8.001 Score on a scale
Interval -10.14 to -5.86
Change From Baseline in Mean Average Score of NRQLQ (Nocturnal Rhino Conjunctivitis Quality of Life Questionnaire) for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 14
Practical Problems
-3.591 Score on a scale
Interval -4.74 to -2.44
-3.208 Score on a scale
Interval -4.34 to -2.07
-3.054 Score on a scale
Interval -4.25 to -1.86

PRIMARY outcome

Timeframe: At Baseline and Day 7

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lower CQ7 scores reflect better nasal patency.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 7
-6.845 Score on a scale
Interval -9.28 to -4.41
-5.137 Score on a scale
Interval -7.53 to -2.74
-8.184 Score on a scale
Interval -10.75 to -5.62

PRIMARY outcome

Timeframe: At Baseline and Day 14

Participants answered following questions of CQ7 questionnaire: Q1 -How often did you have nasal stuffiness, blockage, or congestion?, Q2- How often did you have sinus pressure or pain in your face?, Q3-How often did you have to breathe through your mouth because you could not breathe through your nose?, Q4-How often did you have difficulty completely clearing your nose even after repeated blowing?, Q5-How often did any of these symptoms affect your ability to work, learn in school, or do the things you need to do?, Q6-How often did you awaken in the morning with nasal stuffiness, blockage, or congestion?, Q7-How often was your sleep affected by your nasal stuffiness, blockage, or congestion?. Their responses were scored using a 5 point scale where 0=none of the time; 1=a little of the time, 2=some of the time, 3=most of the time, 4=all of the time. Lowe CQ7 scores reflect better nasal patency.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Sum of 7 Questions of Congestion Quantifier 7 Questionnaire (CQ7) at Day 14
-8.035 Score on a Scale
Interval -10.34 to -5.73
-5.102 Score on a Scale
Interval -7.37 to -2.83
-6.917 Score on a Scale
Interval -9.35 to -4.49

PRIMARY outcome

Timeframe: Day 7

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=19 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
Before strip application
32.10 Score on scale
Standard Deviation 22.386
36.37 Score on scale
Standard Deviation 21.945
40.53 Score on scale
Standard Deviation 18.234
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
After strip application
58.95 Score on scale
Standard Deviation 28.543
47.42 Score on scale
Standard Deviation 26.742
61.11 Score on scale
Standard Deviation 21.787
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 7
Change from Baseline
23.25 Score on scale
Standard Deviation 72.4
8.75 Score on scale
Standard Deviation 24.0
18.89 Score on scale
Standard Deviation 46.6

PRIMARY outcome

Timeframe: Day 14

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14
Before strip application
39.90 Score on a scale
Standard Deviation 24.070
43.21 Score on a scale
Standard Deviation 24.001
45.89 Score on a scale
Standard Deviation 22.292
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime on Day 14
After strip application
68.70 Score on a scale
Standard Deviation 26.636
51.05 Score on a scale
Standard Deviation 25.387
67.56 Score on a scale
Standard Deviation 23.605

PRIMARY outcome

Timeframe: Day 7

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7
Before strip removal
60.15 Score on a Scale
Standard Deviation 25.522
46.95 Score on a Scale
Standard Deviation 25.888
62.63 Score on a Scale
Standard Deviation 19.774
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 7
After strip removal
43.10 Score on a Scale
Standard Deviation 21.711
44.74 Score on a Scale
Standard Deviation 25.236
60.00 Score on a Scale
Standard Deviation 21.654

PRIMARY outcome

Timeframe: Day 14

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on 100 point VAS scale where 0=extremely difficult to breathe and 100=extremely easy

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.
Before Strip Removal
67.80 Score on a scale
Standard Deviation 24.816
48.95 Score on a scale
Standard Deviation 26.511
70.61 Score on a scale
Standard Deviation 22.078
Mean Score in Response to Daily Diary VAS Scale Questions Before and After Strip Removal in Morning on Day 14.
After Strip Removal
51.35 Score on a scale
Standard Deviation 25.203
45.26 Score on a scale
Standard Deviation 25.473
61.11 Score on a scale
Standard Deviation 21.978

PRIMARY outcome

Timeframe: Day 7

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for Q4.)

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
Before strip application (Q2)
1.75 Score on a Scale
Standard Deviation 0.550
1.70 Score on a Scale
Standard Deviation 0.733
1.63 Score on a Scale
Standard Deviation 0.597
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
After strip application (Q2)
1.00 Score on a Scale
Standard Deviation 0.795
1.55 Score on a Scale
Standard Deviation 0.887
1.16 Score on a Scale
Standard Deviation 0.688
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 7
After strip application (Q4)
2.80 Score on a Scale
Standard Deviation 1.399
1.20 Score on a Scale
Standard Deviation 1.473
1.79 Score on a Scale
Standard Deviation 1.475

PRIMARY outcome

Timeframe: Day 14

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip application (Q2) and how breathing felt after strip was applied (Q4) at bedtime. For Q2, the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip application only therefore no data for before application is available for question 4.)

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
Before strip application (Q2)
1.40 Score on a scale
Standard Deviation 0.598
1.58 Score on a scale
Standard Deviation 0.607
1.61 Score on a scale
Standard Deviation 0.698
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
After strip application (Q2)
0.85 Score on a scale
Standard Deviation 0.875
1.35 Score on a scale
Standard Deviation 0.786
1.06 Score on a scale
Standard Deviation 0.873
Mean Score in Response to Daily Diary Questions (Q2 and Q4) at Bedtime on Day 14
After strip application (Q4)
2.70 Score on a scale
Standard Deviation 1.658
0.89 Score on a scale
Standard Deviation 1.410
2.00 Score on a scale
Standard Deviation 1.715

PRIMARY outcome

Timeframe: Day 7

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better. (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
Before strip removal (Q2)
1.00 Score on a scale
Standard Deviation 0.649
1.60 Score on a scale
Standard Deviation 0.995
1.00 Score on a scale
Standard Deviation 0.745
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
After strip removal (Q2)
1.35 Score on a scale
Standard Deviation 0.671
1.75 Score on a scale
Standard Deviation 0.967
1.11 Score on a scale
Standard Deviation 0.809
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 7
After strip removal (Q4)
-0.20 Score on a scale
Standard Deviation 2.118
0.60 Score on a scale
Standard Deviation 1.759
1.16 Score on a scale
Standard Deviation 2.007

PRIMARY outcome

Timeframe: Day 14

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Questions regarding nasal strips were asked to participants and scores were noted on daily basis. Participants were asked how stuffed their nose felt before and after strip removal (Q2) and how breathing felt after strip was removed (Q4) in morning. For Q2 the participants scored their responses on a scale of 0 to 3 where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms. For Q4, participants scored their responses on a scale of -5 to 5 where -5=much worse, 0=same, and 5=much better (Q4 was asked after strip removal only therefore no data for before removal is available for question 4.)

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
Before strip removal (Q2)
0.95 Score ona scale
Standard Deviation 0.826
1.40 Score ona scale
Standard Deviation 0.940
0.89 Score ona scale
Standard Deviation 0.832
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
After strip removal (Q2)
1.30 Score ona scale
Standard Deviation 0.657
1.45 Score ona scale
Standard Deviation 0.887
1.17 Score ona scale
Standard Deviation 0.707
Mean Score in Response to Daily Diary Questions (Q2 and Q4) in Morning on Day 14
After strip removal (Q4)
-0.45 Score ona scale
Standard Deviation 2.282
0.60 Score ona scale
Standard Deviation 1.536
0.94 Score ona scale
Standard Deviation 2.261

SECONDARY outcome

Timeframe: At Day 7 and Day 14

The following questions were asked from Section A (Q1 to Q12; 2 Not getting enough sleep, 4 Poor alertness during the daytime, 5 Difficulty keeping your thoughts focused, 6 Others noticing you appeared tired or fatigued, 7 too many difficulties to overcome, 8 Bad moods because you had poor sleep, 9 Lack of energy because of poor sleep, 10 Poor sleep that interferes with your relationships, 11 Being unable to sleep, 12 Being able to do only enough to get by, Section B (Q13 to Q16; 13 From the time you tried to go to sleep, How long did it take to fall asleep on most nights, 14 If you woke during the night, how long did it take to fall back to sleep on most nights,15 Not counting times when you were awake in bed, how many hours of actual sleep did you get during the worst night, 16 On how many days did you have trouble coping because of poor sleep and Section C (Q17 to Q20;, 19 The regularity of your sleep, 20 The soundness of your sleep)

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary for Other Questions of PIRS Questionnaire
Q2 (Day 7)
1.20 Score on a Scale
Standard Deviation 0.894
1.40 Score on a Scale
Standard Deviation 0.883
1.37 Score on a Scale
Standard Deviation 0.831
Summary for Other Questions of PIRS Questionnaire
Q2 (Day 14)
0.90 Score on a Scale
Standard Deviation 0.788
1.20 Score on a Scale
Standard Deviation 0.834
0.95 Score on a Scale
Standard Deviation 0.705
Summary for Other Questions of PIRS Questionnaire
Q4 (Day7)
0.75 Score on a Scale
Standard Deviation 0.786
1.05 Score on a Scale
Standard Deviation 0.945
0.84 Score on a Scale
Standard Deviation 0.834
Summary for Other Questions of PIRS Questionnaire
Q4 (Day 14)
0.65 Score on a Scale
Standard Deviation 0.745
0.90 Score on a Scale
Standard Deviation 0.788
0.63 Score on a Scale
Standard Deviation 0.684
Summary for Other Questions of PIRS Questionnaire
Q5 (Day 7)
0.65 Score on a Scale
Standard Deviation 0.671
0.85 Score on a Scale
Standard Deviation 0.813
0.63 Score on a Scale
Standard Deviation 0.684
Summary for Other Questions of PIRS Questionnaire
Q5 (Day 14)
0.55 Score on a Scale
Standard Deviation 0.605
0.65 Score on a Scale
Standard Deviation 0.813
0.63 Score on a Scale
Standard Deviation 0.597
Summary for Other Questions of PIRS Questionnaire
Q6 (Day 7)
0.50 Score on a Scale
Standard Deviation 0.827
0.70 Score on a Scale
Standard Deviation 0.923
0.68 Score on a Scale
Standard Deviation 0.820
Summary for Other Questions of PIRS Questionnaire
Q6 (Day 14)
0.50 Score on a Scale
Standard Deviation 0.761
0.60 Score on a Scale
Standard Deviation 0.754
0.58 Score on a Scale
Standard Deviation 0.692
Summary for Other Questions of PIRS Questionnaire
Q7 (Day 7)
0.45 Score on a Scale
Standard Deviation 0.686
0.60 Score on a Scale
Standard Deviation 0.883
0.37 Score on a Scale
Standard Deviation 0.597
Summary for Other Questions of PIRS Questionnaire
Q7 (Day 14)
0.45 Score on a Scale
Standard Deviation 0.826
0.40 Score on a Scale
Standard Deviation 0.681
0.32 Score on a Scale
Standard Deviation 0.478
Summary for Other Questions of PIRS Questionnaire
Q8 (Day 7)
0.65 Score on a Scale
Standard Deviation 0.813
0.80 Score on a Scale
Standard Deviation 0.894
0.63 Score on a Scale
Standard Deviation 0.684
Summary for Other Questions of PIRS Questionnaire
Q8 (Day 14)
0.65 Score on a Scale
Standard Deviation 0.745
0.55 Score on a Scale
Standard Deviation 0.686
0.37 Score on a Scale
Standard Deviation 0.597
Summary for Other Questions of PIRS Questionnaire
Q9 (Day 7)
0.95 Score on a Scale
Standard Deviation 0.826
1.40 Score on a Scale
Standard Deviation 0.995
0.89 Score on a Scale
Standard Deviation 0.658
Summary for Other Questions of PIRS Questionnaire
Q9 (Day 14)
0.80 Score on a Scale
Standard Deviation 0.834
0.85 Score on a Scale
Standard Deviation 0.813
0.68 Score on a Scale
Standard Deviation 0.749
Summary for Other Questions of PIRS Questionnaire
Q10 (Day 7)
0.60 Score on a Scale
Standard Deviation 0.883
0.60 Score on a Scale
Standard Deviation 0.940
0.37 Score on a Scale
Standard Deviation 0.597
Summary for Other Questions of PIRS Questionnaire
Q10 (Day 14)
0.40 Score on a Scale
Standard Deviation 0.754
0.55 Score on a Scale
Standard Deviation 0.887
0.37 Score on a Scale
Standard Deviation 0.597
Summary for Other Questions of PIRS Questionnaire
Q11 (Day 7)
0.70 Score on a Scale
Standard Deviation 0.801
1.30 Score on a Scale
Standard Deviation 0.979
1.00 Score on a Scale
Standard Deviation 0.745
Summary for Other Questions of PIRS Questionnaire
Q11 (Day 14)
0.70 Score on a Scale
Standard Deviation 0.865
1.05 Score on a Scale
Standard Deviation 0.887
0.68 Score on a Scale
Standard Deviation 0.749
Summary for Other Questions of PIRS Questionnaire
Q12 (Day 7)
0.40 Score on a Scale
Standard Deviation 0.754
0.70 Score on a Scale
Standard Deviation 0.733
0.63 Score on a Scale
Standard Deviation 0.761
Summary for Other Questions of PIRS Questionnaire
Q12 (Day 14)
0.30 Score on a Scale
Standard Deviation 0.733
0.60 Score on a Scale
Standard Deviation 0.821
0.32 Score on a Scale
Standard Deviation 0.582
Summary for Other Questions of PIRS Questionnaire
Q13 (Day 7)
0.45 Score on a Scale
Standard Deviation 0.605
0.70 Score on a Scale
Standard Deviation 0.733
0.74 Score on a Scale
Standard Deviation 0.733
Summary for Other Questions of PIRS Questionnaire
Q13 (Day 14)
0.55 Score on a Scale
Standard Deviation 0.605
0.60 Score on a Scale
Standard Deviation 0.754
0.63 Score on a Scale
Standard Deviation 0.761
Summary for Other Questions of PIRS Questionnaire
Q14 (Day 7)
0.35 Score on a Scale
Standard Deviation 0.489
0.65 Score on a Scale
Standard Deviation 0.745
0.53 Score on a Scale
Standard Deviation 0.697
Summary for Other Questions of PIRS Questionnaire
Q14 (Day 14)
0.45 Score on a Scale
Standard Deviation 0.605
0.55 Score on a Scale
Standard Deviation 0.605
0.53 Score on a Scale
Standard Deviation 0.612
Summary for Other Questions of PIRS Questionnaire
Q15 (Day 7)
1.00 Score on a Scale
Standard Deviation 0.324
1.20 Score on a Scale
Standard Deviation 0.616
1.32 Score on a Scale
Standard Deviation 0.582
Summary for Other Questions of PIRS Questionnaire
Q15 (Day 14)
1.05 Score on a Scale
Standard Deviation 0.394
1.05 Score on a Scale
Standard Deviation 0.510
1.05 Score on a Scale
Standard Deviation 0.621
Summary for Other Questions of PIRS Questionnaire
Q16 (Day 7)
0.40 Score on a Scale
Standard Deviation 0.754
0.74 Score on a Scale
Standard Deviation 0.933
0.47 Score on a Scale
Standard Deviation 0.697
Summary for Other Questions of PIRS Questionnaire
Q16 (Day 14)
0.25 Score on a Scale
Standard Deviation 0.716
0.50 Score on a Scale
Standard Deviation 0.688
0.32 Score on a Scale
Standard Deviation 0.582
Summary for Other Questions of PIRS Questionnaire
Q 19 (Day 7)
1.40 Score on a Scale
Standard Deviation 0.754
2.00 Score on a Scale
Standard Deviation 0.795
1.68 Score on a Scale
Standard Deviation 0.671
Summary for Other Questions of PIRS Questionnaire
Q19 (Day 14)
1.35 Score on a Scale
Standard Deviation 0.587
1.70 Score on a Scale
Standard Deviation 0.865
1.26 Score on a Scale
Standard Deviation 0.733
Summary for Other Questions of PIRS Questionnaire
Q20 (Day 7)
1.30 Score on a Scale
Standard Deviation 0.923
1.85 Score on a Scale
Standard Deviation 0.933
1.63 Score on a Scale
Standard Deviation 0.684
Summary for Other Questions of PIRS Questionnaire
Q20 (Day 14)
1.40 Score on a Scale
Standard Deviation 0.821
1.75 Score on a Scale
Standard Deviation 0.967
1.21 Score on a Scale
Standard Deviation 0.713

SECONDARY outcome

Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment

Participants were asked how easy it was to breathe through their nose before and after strip application at bedtime. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 3)
58.90 Score on a scale
Standard Deviation 26.638
48.53 Score on a scale
Standard Deviation 20.665
61.42 Score on a scale
Standard Deviation 24.739
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 1)
27.85 Score on a scale
Standard Deviation 20.582
34.58 Score on a scale
Standard Deviation 15.798
34.00 Score on a scale
Standard Deviation 14.821
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 1)
61.55 Score on a scale
Standard Deviation 26.716
43.11 Score on a scale
Standard Deviation 24.071
55.00 Score on a scale
Standard Deviation 24.866
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 2)
28.2 Score on a scale
Standard Deviation 20.18
37.2 Score on a scale
Standard Deviation 23.18
42.7 Score on a scale
Standard Deviation 19.26
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 2)
60.1 Score on a scale
Standard Deviation 26.16
45.2 Score on a scale
Standard Deviation 25.04
60.7 Score on a scale
Standard Deviation 22.36
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 3)
29.35 Score on a scale
Standard Deviation 20.296
37.95 Score on a scale
Standard Deviation 19.842
45.11 Score on a scale
Standard Deviation 23.870
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 4)
32.8 Score on a scale
Standard Deviation 20.87
33.3 Score on a scale
Standard Deviation 14.27
36.4 Score on a scale
Standard Deviation 19.29
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After Strip application (Day 4)
60.8 Score on a scale
Standard Deviation 28.86
45.7 Score on a scale
Standard Deviation 17.89
60.2 Score on a scale
Standard Deviation 22.14
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 5)
33.2 Score on a scale
Standard Deviation 23.45
36.9 Score on a scale
Standard Deviation 19.78
41.4 Score on a scale
Standard Deviation 21.85
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 5)
64.9 Score on a scale
Standard Deviation 28.11
47.5 Score on a scale
Standard Deviation 22.51
63.8 Score on a scale
Standard Deviation 23.95
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 6)
28.6 Score on a scale
Standard Deviation 22.47
35.9 Score on a scale
Standard Deviation 20.29
44.9 Score on a scale
Standard Deviation 18.55
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 6)
60.5 Score on a scale
Standard Deviation 30.06
44.8 Score on a scale
Standard Deviation 21.28
64.3 Score on a scale
Standard Deviation 20.03
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 8)
35.4 Score on a scale
Standard Deviation 22.08
38.6 Score on a scale
Standard Deviation 21.38
45.5 Score on a scale
Standard Deviation 19.18
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 8)
61.2 Score on a scale
Standard Deviation 26.41
47.8 Score on a scale
Standard Deviation 25.07
65.0 Score on a scale
Standard Deviation 22.96
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 9)
32.7 Score on a scale
Standard Deviation 24.11
40.0 Score on a scale
Standard Deviation 21.18
45.6 Score on a scale
Standard Deviation 19.90
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 9)
61.2 Score on a scale
Standard Deviation 27.90
48.6 Score on a scale
Standard Deviation 24.45
63.4 Score on a scale
Standard Deviation 22.45
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 10)
36.9 Score on a scale
Standard Deviation 25.80
42.7 Score on a scale
Standard Deviation 27.71
40.6 Score on a scale
Standard Deviation 19.74
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 10)
68.3 Score on a scale
Standard Deviation 27.76
50.2 Score on a scale
Standard Deviation 30.15
60.9 Score on a scale
Standard Deviation 24.91
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 11)
66.3 Score on a scale
Standard Deviation 26.45
49.8 Score on a scale
Standard Deviation 25.18
63.2 Score on a scale
Standard Deviation 25.60
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 11)
33.6 Score on a scale
Standard Deviation 25.33
40.2 Score on a scale
Standard Deviation 22.99
42.1 Score on a scale
Standard Deviation 21.52
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 12)
32.7 Score on a scale
Standard Deviation 25.79
42.5 Score on a scale
Standard Deviation 24.96
47.5 Score on a scale
Standard Deviation 21.51
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 12)
66.8 Score on a scale
Standard Deviation 27.43
52.8 Score on a scale
Standard Deviation 26.46
65.7 Score on a scale
Standard Deviation 23.44
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 13)
33.9 Score on a scale
Standard Deviation 27.28
43.5 Score on a scale
Standard Deviation 23.07
48.1 Score on a scale
Standard Deviation 24.12
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 13)
66.7 Score on a scale
Standard Deviation 26.62
53.1 Score on a scale
Standard Deviation 26.16
67.8 Score on a scale
Standard Deviation 24.38

SECONDARY outcome

Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how easy it was to breathe through their nose before and after strip removal in morning. The participants scored their responses on VAS scale where 0 = extremely difficult to breathe and 100 = extremely easy to breathe. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 1)
54.60 Score on a scale
Standard Deviation 30.407
45.11 Score on a scale
Standard Deviation 22.588
60.44 Score on a scale
Standard Deviation 20.024
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 1)
44.75 Score on a scale
Standard Deviation 21.560
41.47 Score on a scale
Standard Deviation 20.018
51.44 Score on a scale
Standard Deviation 20.569
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 2)
61.0 Score on a scale
Standard Deviation 26.25
44.1 Score on a scale
Standard Deviation 22.56
60.0 Score on a scale
Standard Deviation 22.85
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 2)
46.8 Score on a scale
Standard Deviation 21.80
42.1 Score on a scale
Standard Deviation 22.34
51.2 Score on a scale
Standard Deviation 21.76
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 3)
63.60 Score on a scale
Standard Deviation 27.582
48.37 Score on a scale
Standard Deviation 23.864
60.21 Score on a scale
Standard Deviation 24.114
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 3)
44.90 Score on a scale
Standard Deviation 21.071
45.53 Score on a scale
Standard Deviation 23.236
56.79 Score on a scale
Standard Deviation 21.578
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 4)
64.9 Score on a scale
Standard Deviation 26.35
50.0 Score on a scale
Standard Deviation 19.06
62.8 Score on a scale
Standard Deviation 21.56
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 4)
49.2 Score on a scale
Standard Deviation 23.37
45.9 Score on a scale
Standard Deviation 21.27
53.6 Score on a scale
Standard Deviation 20.99
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 5)
65.0 Score on a scale
Standard Deviation 27.48
47.4 Score on a scale
Standard Deviation 21.94
64.0 Score on a scale
Standard Deviation 20.90
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 5)
49.7 Score on a scale
Standard Deviation 23.50
43.4 Score on a scale
Standard Deviation 23.21
58.1 Score on a scale
Standard Deviation 19.31
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 6)
60.9 Score on a scale
Standard Deviation 27.34
46.2 Score on a scale
Standard Deviation 23.94
63.1 Score on a scale
Standard Deviation 21.40
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 6)
47.0 Score on a scale
Standard Deviation 24.03
42.4 Score on a scale
Standard Deviation 23.16
58.6 Score on a scale
Standard Deviation 18.40
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 8)
64.7 Score on a scale
Standard Deviation 25.34
43.6 Score on a scale
Standard Deviation 25.55
65.2 Score on a scale
Standard Deviation 20.39
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 8)
46.6 Score on a scale
Standard Deviation 25.50
40.7 Score on a scale
Standard Deviation 24.07
60.4 Score on a scale
Standard Deviation 19.35
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 9)
61.1 Score on a scale
Standard Deviation 27.82
46.7 Score on a scale
Standard Deviation 24.68
65.1 Score on a scale
Standard Deviation 23.06
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 9)
49.0 Score on a scale
Standard Deviation 26.34
41.7 Score on a scale
Standard Deviation 24.08
59.5 Score on a scale
Standard Deviation 20.19
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 10)
66.2 Score on a scale
Standard Deviation 25.85
45.6 Score on a scale
Standard Deviation 26.88
65.4 Score on a scale
Standard Deviation 22.52
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 10)
50.6 Score on a scale
Standard Deviation 24.92
42.4 Score on a scale
Standard Deviation 26.57
57.5 Score on a scale
Standard Deviation 22.10
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 11)
62.3 Score on a scale
Standard Deviation 26.37
47.3 Score on a scale
Standard Deviation 25.79
67.5 Score on a scale
Standard Deviation 20.50
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 11)
46.4 Score on a scale
Standard Deviation 23.93
42.2 Score on a scale
Standard Deviation 23.98
57.0 Score on a scale
Standard Deviation 19.91
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 12)
63.8 Score on a scale
Standard Deviation 25.58
49.2 Score on a scale
Standard Deviation 24.95
67.6 Score on a scale
Standard Deviation 21.03
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 12)
48.7 Score on a scale
Standard Deviation 27.39
46.3 Score on a scale
Standard Deviation 23.45
59.4 Score on a scale
Standard Deviation 21.30
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
Before strip removal (Day 13)
64.3 Score on a scale
Standard Deviation 25.58
46.4 Score on a scale
Standard Deviation 26.18
68.4 Score on a scale
Standard Deviation 22.84
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning
After strip removal (Day 13)
46.6 Score on a scale
Standard Deviation 27.39
43.3 Score on a scale
Standard Deviation 26.37
60.0 Score on a scale
Standard Deviation 21.02

SECONDARY outcome

Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how open their nose feels before and after strip application at bedtime. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 1)
27.90 Score on a Scale
Standard Deviation 20.463
37.74 Score on a Scale
Standard Deviation 17.143
35.89 Score on a Scale
Standard Deviation 14.644
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 1)
61.45 Score on a Scale
Standard Deviation 25.853
45.84 Score on a Scale
Standard Deviation 23.061
57.68 Score on a Scale
Standard Deviation 22.583
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 2)
27.5 Score on a Scale
Standard Deviation 19.64
38.3 Score on a Scale
Standard Deviation 22.17
42.2 Score on a Scale
Standard Deviation 19.49
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 2)
59.8 Score on a Scale
Standard Deviation 26.90
47.0 Score on a Scale
Standard Deviation 24.10
63.2 Score on a Scale
Standard Deviation 63.2
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 3)
30.05 Score on a Scale
Standard Deviation 20.405
38.32 Score on a Scale
Standard Deviation 19.285
46.42 Score on a Scale
Standard Deviation 24.132
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 3)
59.25 Score on a Scale
Standard Deviation 27.466
49.74 Score on a Scale
Standard Deviation 22.098
62.16 Score on a Scale
Standard Deviation 24.847
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 4)
32.6 Score on a Scale
Standard Deviation 20.51
33.6 Score on a Scale
Standard Deviation 14.78
36.6 Score on a Scale
Standard Deviation 18.74
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 4)
60.5 Score on a Scale
Standard Deviation 28.31
46.7 Score on a Scale
Standard Deviation 17.34
61.1 Score on a Scale
Standard Deviation 23.41
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 5)
33.4 Score on a Scale
Standard Deviation 23.85
36.1 Score on a Scale
Standard Deviation 19.57
42.1 Score on a Scale
Standard Deviation 21.60
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip appliation (Day 5)
65.6 Score on a Scale
Standard Deviation 28.44
49.3 Score on a Scale
Standard Deviation 22.62
66.7 Score on a Scale
Standard Deviation 23.97
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 6)
26.7 Score on a Scale
Standard Deviation 20.58
35.3 Score on a Scale
Standard Deviation 18.59
44.8 Score on a Scale
Standard Deviation 20.14
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 6)
60.5 Score on a Scale
Standard Deviation 28.86
43.9 Score on a Scale
Standard Deviation 19.34
66.5 Score on a Scale
Standard Deviation 20.92
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 8)
33.9 Score on a Scale
Standard Deviation 21.15
37.9 Score on a Scale
Standard Deviation 22.54
46.9 Score on a Scale
Standard Deviation 20.76
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 8)
63.4 Score on a Scale
Standard Deviation 26.94
46.5 Score on a Scale
Standard Deviation 24.74
67.5 Score on a Scale
Standard Deviation 67.5
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 9)
32.7 Score on a Scale
Standard Deviation 24.42
37.6 Score on a Scale
Standard Deviation 20.70
45.8 Score on a Scale
Standard Deviation 21.77
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 9)
65.6 Score on a Scale
Standard Deviation 26.71
49.5 Score on a Scale
Standard Deviation 25.34
65.5 Score on a Scale
Standard Deviation 23.09
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 10)
36.2 Score on a Scale
Standard Deviation 42.1
42.1 Score on a Scale
Standard Deviation 26.94
41.8 Score on a Scale
Standard Deviation 22.31
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 10)
68.7 Score on a Scale
Standard Deviation 26.85
52.1 Score on a Scale
Standard Deviation 30.45
63.0 Score on a Scale
Standard Deviation 25.34
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 11)
35.4 Score on a Scale
Standard Deviation 24.79
41.3 Score on a Scale
Standard Deviation 23.74
41.3 Score on a Scale
Standard Deviation 22.54
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 11)
67.3 Score on a Scale
Standard Deviation 26.69
50.5 Score on a Scale
Standard Deviation 27.02
64.8 Score on a Scale
Standard Deviation 25.15
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 12)
34.7 Score on a Scale
Standard Deviation 26.71
44.2 Score on a Scale
Standard Deviation 24.78
47.5 Score on a Scale
Standard Deviation 23.30
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 12)
68.4 Score on a Scale
Standard Deviation 26.67
53.4 Score on a Scale
Standard Deviation 26.40
67.5 Score on a Scale
Standard Deviation 23.95
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
Before strip application (Day 13)
34.9 Score on a Scale
Standard Deviation 26.36
42.7 Score on a Scale
Standard Deviation 23.58
50.3 Score on a Scale
Standard Deviation 24.75
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Application at Bedtime
After strip application (Day 13)
67.1 Score on a Scale
Standard Deviation 25.90
53.6 Score on a Scale
Standard Deviation 25.74
68.1 Score on a Scale
Standard Deviation 25.28

SECONDARY outcome

Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how open their nose feels before and after strip removal in morning. The participants scored their responses VAS scale where 0 = nose was extremely blocked and 100 = nose was extremely clear. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 1)
53.95 Score on a Scale
Standard Deviation 29.883
45.37 Score on a Scale
Standard Deviation 25.049
60.22 Score on a Scale
Standard Deviation 21.198
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 1)
44.70 Score on a Scale
Standard Deviation 22.181
42.53 Score on a Scale
Standard Deviation 20.291
51.56 Score on a Scale
Standard Deviation 22.727
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 2)
60.8 Score on a Scale
Standard Deviation 26.46
43.7 Score on a Scale
Standard Deviation 20.85
60.6 Score on a Scale
Standard Deviation 23.48
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 2)
45.7 Score on a Scale
Standard Deviation 23.56
43.4 Score on a Scale
Standard Deviation 22.56
53.1 Score on a Scale
Standard Deviation 22.81
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 3)
61.35 Score on a Scale
Standard Deviation 27.871
46.89 Score on a Scale
Standard Deviation 23.812
60.53 Score on a Scale
Standard Deviation 24.688
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 3)
44.30 Score on a Scale
Standard Deviation 21.440
45.47 Score on a Scale
Standard Deviation 22.473
58.11 Score on a Scale
Standard Deviation 22.652
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 4)
63.7 Score on a Scale
Standard Deviation 25.51
48.2 Score on a Scale
Standard Deviation 19.23
64.7 Score on a Scale
Standard Deviation 22.55
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 4)
48.3 Score on a Scale
Standard Deviation 22.10
45.5 Score on a Scale
Standard Deviation 21.18
55.1 Score on a Scale
Standard Deviation 21.13
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 5)
65.2 Score on a Scale
Standard Deviation 27.66
45.2 Score on a Scale
Standard Deviation 23.74
64.4 Score on a Scale
Standard Deviation 20.52
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 5)
49.3 Score on a Scale
Standard Deviation 25.08
43.4 Score on a Scale
Standard Deviation 23.30
59.6 Score on a Scale
Standard Deviation 20.14
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 6)
60.4 Score on a Scale
Standard Deviation 27.25
45.9 Score on a Scale
Standard Deviation 24.34
64.9 Score on a Scale
Standard Deviation 22.29
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 6)
45.0 Score on a Scale
Standard Deviation 22.74
45.6 Score on a Scale
Standard Deviation 22.77
58.8 Score on a Scale
Standard Deviation 19.74
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 8)
65.3 Score on a Scale
Standard Deviation 25.65
41.6 Score on a Scale
Standard Deviation 25.54
66.7 Score on a Scale
Standard Deviation 21.14
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 8)
46.9 Score on a Scale
Standard Deviation 26.82
42.5 Score on a Scale
Standard Deviation 24.62
59.7 Score on a Scale
Standard Deviation 19.85
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 9)
62.8 Score on a Scale
Standard Deviation 25.86
43.3 Score on a Scale
Standard Deviation 24.41
65.5 Score on a Scale
Standard Deviation 21.99
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 9)
48.3 Score on a Scale
Standard Deviation 27.55
40.1 Score on a Scale
Standard Deviation 24.98
60.2 Score on a Scale
Standard Deviation 20.34
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 10)
66.1 Score on a Scale
Standard Deviation 25.67
43.1 Score on a Scale
Standard Deviation 26.52
67.1 Score on a Scale
Standard Deviation 23.01
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 10)
50.6 Score on a Scale
Standard Deviation 25.43
42.7 Score on a Scale
Standard Deviation 26.55
57.6 Score on a Scale
Standard Deviation 22.72
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 11)
61.6 Score on a Scale
Standard Deviation 26.54
44.3 Score on a Scale
Standard Deviation 25.67
67.2 Score on a Scale
Standard Deviation 21.63
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 11)
47.1 Score on a Scale
Standard Deviation 23.92
42.2 Score on a Scale
Standard Deviation 24.54
24.54 Score on a Scale
Standard Deviation 20.87
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 12)
63.1 Score on a Scale
Standard Deviation 26.12
46.5 Score on a Scale
Standard Deviation 23.72
69.2 Score on a Scale
Standard Deviation 20.81
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 12)
49.7 Score on a Scale
Standard Deviation 27.52
47.4 Score on a Scale
Standard Deviation 21.72
61.8 Score on a Scale
Standard Deviation 22.26
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
Before strip removal (Day 13)
64.9 Score on a Scale
Standard Deviation 25.41
40.9 Score on a Scale
Standard Deviation 24.83
68.6 Score on a Scale
Standard Deviation 22.41
Summary of Other Daily Diary VAS Scale Questions Before and After Strip Removal in Morning.
After strip removal (Day 13)
46.4 Score on a Scale
Standard Deviation 28.24
42.3 Score on a Scale
Standard Deviation 24.85
61.0 Score on a Scale
Standard Deviation 22.33

SECONDARY outcome

Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment

Participants were asked how stuffed their nose felt before and after strip application at bed time. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 1)
1.95 Score on a scale
Standard Deviation 0.394
2.00 Score on a scale
Standard Deviation 0.562
1.79 Score on a scale
Standard Deviation 0.535
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 1)
1.10 Score on a scale
Standard Deviation 0.788
1.80 Score on a scale
Standard Deviation 0.696
1.26 Score on a scale
Standard Deviation 0.562
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 2)
1.80 Score on a scale
Standard Deviation 0.696
1.85 Score on a scale
Standard Deviation 0.587
1.53 Score on a scale
Standard Deviation 0.612
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 2)
1.05 Score on a scale
Standard Deviation 0.686
1.70 Score on a scale
Standard Deviation 0.733
1.11 Score on a scale
Standard Deviation 0.658
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 3)
1.90 Score on a scale
Standard Deviation 0.641
1.90 Score on a scale
Standard Deviation 0.553
1.58 Score on a scale
Standard Deviation 0.692
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 3)
1.16 Score on a scale
Standard Deviation 0.898
1.60 Score on a scale
Standard Deviation 0.754
1.16 Score on a scale
Standard Deviation 0.688
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 4)
1.55 Score on a scale
Standard Deviation 0.686
1.70 Score on a scale
Standard Deviation 0.733
1.74 Score on a scale
Standard Deviation 0.562
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 4)
0.95 Score on a scale
Standard Deviation 0.887
1.55 Score on a scale
Standard Deviation 0.759
1.16 Score on a scale
Standard Deviation 0.602
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 5)
1.75 Score on a scale
Standard Deviation 0.550
1.65 Score on a scale
Standard Deviation 0.671
1.53 Score on a scale
Standard Deviation 0.772
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 5)
1.00 Score on a scale
Standard Deviation 0.795
1.50 Score on a scale
Standard Deviation 0.761
1.21 Score on a scale
Standard Deviation 0.855
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 6)
1.90 Score on a scale
Standard Deviation 0.641
1.75 Score on a scale
Standard Deviation 0.716
1.53 Score on a scale
Standard Deviation 0.697
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 6)
1.00 Score on a scale
Standard Deviation 0.795
1.65 Score on a scale
Standard Deviation 0.813
1.16 Score on a scale
Standard Deviation 0.501
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 8)
1.70 Score on a scale
Standard Deviation 0.571
1.70 Score on a scale
Standard Deviation 0.571
1.47 Score on a scale
Standard Deviation 0.513
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 13)
1.75 Score on a scale
Standard Deviation 0.639
1.50 Score on a scale
Standard Deviation 0.688
1.39 Score on a scale
Standard Deviation 0.850
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 8)
1.15 Score on a scale
Standard Deviation 0.813
1.47 Score on a scale
Standard Deviation 0.772
0.83 Score on a scale
Standard Deviation 0.786
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 9)
1.70 Score on a scale
Standard Deviation 0.571
1.58 Score on a scale
Standard Deviation 0.838
1.39 Score on a scale
Standard Deviation 0.608
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 9)
1.05 Score on a scale
Standard Deviation 0.826
1.37 Score on a scale
Standard Deviation 0.955
1.05 Score on a scale
Standard Deviation 0.705
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 10)
1.60 Score on a scale
Standard Deviation 0.598
1.65 Score on a scale
Standard Deviation 0.933
1.37 Score on a scale
Standard Deviation 0.831
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 10)
0.95 Score on a scale
Standard Deviation 0.945
1.50 Score on a scale
Standard Deviation 1.051
1.21 Score on a scale
Standard Deviation 0.918
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 11)
1.68 Score on a scale
Standard Deviation 0.671
1.60 Score on a scale
Standard Deviation 0.821
1.56 Score on a scale
Standard Deviation 0.616
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 11)
1.15 Score on a scale
Standard Deviation 0.875
1.45 Score on a scale
Standard Deviation 0.945
1.11 Score on a scale
Standard Deviation 0.676
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
Before strip application (Day 12)
1.74 Score on a scale
Standard Deviation 0.653
1.40 Score on a scale
Standard Deviation 0.754
1.37 Score on a scale
Standard Deviation 0.684
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip application (Day 12)
1.05 Score on a scale
Standard Deviation 0.911
1.26 Score on a scale
Standard Deviation 0.872
0.95 Score on a scale
Standard Deviation 0.621
Summary of Daily Diary Questions Before and After Strip Application at Bedtime
After strip applications (Day 13)
0.90 Score on a scale
Standard Deviation 0.912
1.35 Score on a scale
Standard Deviation 0.813
1.05 Score on a scale
Standard Deviation 0.848

SECONDARY outcome

Timeframe: At Day 1, Day 2, day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day 13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how stuffed their nose felt before and after strip removal in morning. The participants scored their responses on the scale of 0 to 3 where 0=No symptoms, 1=mild symptoms and 3=severe symptoms. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 1)
1.15 Score on a scale
Standard Deviation 0.745
1.55 Score on a scale
Standard Deviation 0.759
1.22 Score on a scale
Standard Deviation 0.647
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 1)
1.35 Score on a scale
Standard Deviation 0.671
1.65 Score on a scale
Standard Deviation 0.745
1.33 Score on a scale
Standard Deviation 0.594
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 2)
1.05 Score on a scale
Standard Deviation 0.686
1.53 Score on a scale
Standard Deviation 0.905
1.21 Score on a scale
Standard Deviation 0.855
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 2)
1.40 Score on a scale
Standard Deviation 0.681
1.70 Score on a scale
Standard Deviation 0.801
1.32 Score on a scale
Standard Deviation 0.671
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 3)
0.84 Score on a scale
Standard Deviation 0.688
1.45 Score on a scale
Standard Deviation 0.887
1.11 Score on a scale
Standard Deviation 0.737
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 3)
1.35 Score on a scale
Standard Deviation 0.671
1.55 Score on a scale
Standard Deviation 0.826
1.11 Score on a scale
Standard Deviation 0.583
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 4)
0.95 Score on a scale
Standard Deviation 0.826
1.42 Score on a scale
Standard Deviation 0.838
1.00 Score on a scale
Standard Deviation 0.816
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 4)
1.25 Score on a scale
Standard Deviation 0.639
1.55 Score on a scale
Standard Deviation 0.759
1.11 Score on a scale
Standard Deviation 0.658
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 5)
0.95 Score on a scale
Standard Deviation 0.759
1.40 Score on a scale
Standard Deviation 0.821
1.00 Score on a scale
Standard Deviation 0.882
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 5)
1.25 Score on a scale
Standard Deviation 0.786
1.55 Score on a scale
Standard Deviation 0.826
0.95 Score on a scale
Standard Deviation 0.621
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 6)
1.05 Score on a scale
Standard Deviation 0.826
1.55 Score on a scale
Standard Deviation 0.999
1.00 Score on a scale
Standard Deviation 0.816
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 6)
1.40 Score on a scale
Standard Deviation 0.754
1.65 Score on a scale
Standard Deviation 0.933
1.05 Score on a scale
Standard Deviation 0.621
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 8)
1.05 Score on a scale
Standard Deviation 0.759
1.55 Score on a scale
Standard Deviation 0.945
0.84 Score on a scale
Standard Deviation 0.688
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 8)
1.45 Score on a scale
Standard Deviation 0.826
1.68 Score on a scale
Standard Deviation 0.885
1.00 Score on a scale
Standard Deviation 0.745
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 9)
0.95 Score on a scale
Standard Deviation 0.826
1.45 Score on a scale
Standard Deviation 1.050
0.79 Score on a scale
Standard Deviation 0.631
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 9)
1.45 Score on a scale
Standard Deviation 0.826
1.58 Score on a scale
Standard Deviation 1.017
0.95 Score on a scale
Standard Deviation 0.621
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 10)
0.90 Score on a scale
Standard Deviation 0.852
1.60 Score on a scale
Standard Deviation 0.995
1.00 Score on a scale
Standard Deviation 0.767
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 10)
1.20 Score on a scale
Standard Deviation 0.768
1.60 Score on a scale
Standard Deviation 0.940
1.21 Score on a scale
Standard Deviation 0.713
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 11)
1.20 Score on a scale
Standard Deviation 0.834
1.55 Score on a scale
Standard Deviation 0.945
1.00 Score on a scale
Standard Deviation 0.577
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 11)
1.50 Score on a scale
Standard Deviation 0.761
1.70 Score on a scale
Standard Deviation 0.923
1.21 Score on a scale
Standard Deviation 0.631
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 12)
1.00 Score on a scale
Standard Deviation 0.882
1.30 Score on a scale
Standard Deviation 1.031
0.74 Score on a scale
Standard Deviation 0.733
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 12)
1.37 Score on a scale
Standard Deviation 0.831
1.40 Score on a scale
Standard Deviation 0.995
0.95 Score on a scale
Standard Deviation 0.621
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
Before strip removal (Day 13)
0.95 Score on a scale
Standard Deviation 0.826
1.50 Score on a scale
Standard Deviation 1.000
1.00 Score on a scale
Standard Deviation 0.745
Summary of Daily Dairy Questions Before and After Strip Removal in Morning
After strip removal (Day 13)
1.40 Score on a scale
Standard Deviation 0.883
1.65 Score on a scale
Standard Deviation 0.933
1.05 Score on a scale
Standard Deviation 0.848

SECONDARY outcome

Timeframe: At Day 1, Day 2, Day 3, Day 4, Day 5, Day 6, Day 8, Day 9, Day 10, Day 11, Day 12, and Day13

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked how breathing felt after nasal strip was applied at bed time and removed in morning. The participants scored their responses on the scale of -5 to 5 where -5 = much worse, 0 = same and 5= much better. These responses were recorded daily.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 1)
2.45 Score on a scale
Standard Deviation 1.395
1.20 Score on a scale
Standard Deviation 1.473
1.42 Score on a scale
Standard Deviation 2.116
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 1)
-0.30 Score on a scale
Standard Deviation 2.055
0.25 Score on a scale
Standard Deviation 1.650
0.50 Score on a scale
Standard Deviation 2.407
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 2)
1.95 Score on a scale
Standard Deviation 1.932
0.90 Score on a scale
Standard Deviation 1.410
1.53 Score on a scale
Standard Deviation 1.744
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 2)
-0.10 Score on a scale
Standard Deviation 2.075
0.30 Score on a scale
Standard Deviation 1.525
0.26 Score on a scale
Standard Deviation 2.182
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 3)
2.40 Score on a scale
Standard Deviation 1.667
1.20 Score on a scale
Standard Deviation 1.361
1.74 Score on a scale
Standard Deviation 1.727
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 3)
-0.35 Score on a scale
Standard Deviation 2.183
0.85 Score on a scale
Standard Deviation 1.631
0.68 Score on a scale
Standard Deviation 1.734
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 4)
2.70 Score on a scale
Standard Deviation 1.525
1.10 Score on a scale
Standard Deviation 1.334
1.47 Score on a scale
Standard Deviation 1.896
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 4)
-0.50 Score on a scale
Standard Deviation 2.115
0.45 Score on a scale
Standard Deviation 1.731
0.47 Score on a scale
Standard Deviation 2.118
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 5)
2.80 Score on a scale
Standard Deviation 1.765
1.05 Score on a scale
Standard Deviation 1.605
1.63 Score on a scale
Standard Deviation 1.707
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 5)
-0.20 Score on a scale
Standard Deviation 2.397
0.55 Score on a scale
Standard Deviation 1.731
0.84 Score on a scale
Standard Deviation 2.167
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 6)
2.85 Score on a scale
Standard Deviation 1.565
0.95 Score on a scale
Standard Deviation 1.504
1.89 Score on a scale
Standard Deviation 1.629
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 6)
-0.45 Score on a scale
Standard Deviation 2.282
0.50 Score on a scale
Standard Deviation 1.792
0.74 Score on a scale
Standard Deviation 2.077
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 8)
2.65 Score on a scale
Standard Deviation 1.755
0.85 Score on a scale
Standard Deviation 1.309
1.84 Score on a scale
Standard Deviation 1.864
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 8)
-0.45 Score on a scale
Standard Deviation 2.164
0.25 Score on a scale
Standard Deviation 1.164
0.79 Score on a scale
Standard Deviation 2.043
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 9)
2.80 Score on a scale
Standard Deviation 1.576
0.84 Score on a scale
Standard Deviation 1.344
1.84 Score on a scale
Standard Deviation 1.675
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 9)
-0.40 Score on a scale
Standard Deviation 2.415
0.20 Score on a scale
Standard Deviation 1.196
1.00 Score on a scale
Standard Deviation 1.856
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 10)
2.85 Score on a scale
Standard Deviation 1.599
0.95 Score on a scale
Standard Deviation 1.234
1.95 Score on a scale
Standard Deviation 1.580
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 10)
-0.47 Score on a scale
Standard Deviation 2.412
0.25 Score on a scale
Standard Deviation 1.251
1.00 Score on a scale
Standard Deviation 2.082
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 11)
2.60 Score on a scale
Standard Deviation 1.759
0.75 Score on a scale
Standard Deviation 1.293
1.84 Score on a scale
Standard Deviation 1.675
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 11)
-0.65 Score on a scale
Standard Deviation 2.277
0.10 Score on a scale
Standard Deviation 1.410
0.68 Score on a scale
Standard Deviation 2.056
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 12)
2.79 Score on a scale
Standard Deviation 1.782
0.95 Score on a scale
Standard Deviation 1.317
2.00 Score on a scale
Standard Deviation 1.491
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 12)
-0.74 Score on a scale
Standard Deviation 2.306
0.30 Score on a scale
Standard Deviation 1.218
0.89 Score on a scale
Standard Deviation 2.052
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip application (Day 13)
2.65 Score on a scale
Standard Deviation 1.631
0.95 Score on a scale
Standard Deviation 1.317
2.05 Score on a scale
Standard Deviation 1.649
Summary of Daily Diary Questions at Bed Time (After Strip Application) and in Morning (After Strip Removal).
After strip removal (Day 13)
-0.40 Score on a scale
Standard Deviation 2.703
0.35 Score on a scale
Standard Deviation 1.424
0.79 Score on a scale
Standard Deviation 1.988

SECONDARY outcome

Timeframe: At Day 7 and at Day 14

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants scored all the domains of NRQLQ using same 7 points scale where 0=Not troubled and 6=extremely troubled. Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score, scores range: Min-Max \[0-24\]), Sleep time problems (Nasal congestion or stuffy nose, sinus pressure or pain, runny nose, post-nasal drip \[drainage down back of nose/throat\], and headache, scores range: 0-30); Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up, scores range:0-24); practical problems (have to avoid symptom triggers such as dust, cigarette smoke, strong smells and perfumes, need to rub nose or eyes, and have to take medication, scores range: 0-18). Lower scores indicate improvement in the rhinitis symptoms.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep Problems (Day 7)
7.62 Score on a scale
Standard Deviation 6.117
11.58 Score on a scale
Standard Deviation 7.452
6.09 Score on a scale
Standard Deviation 4.826
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep Problems (Day 14)
6.92 Score on a scale
Standard Deviation 5.951
9.75 Score on a scale
Standard Deviation 6.771
4.91 Score on a scale
Standard Deviation 4.134
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep time problems (Day 7)
7.62 Score on a scale
Standard Deviation 6.838
10.08 Score on a scale
Standard Deviation 7.489
6.00 Score on a scale
Standard Deviation 7.225
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Sleep time problems (Day 14)
6.77 Score on a scale
Standard Deviation 7.683
8.50 Score on a scale
Standard Deviation 8.713
6.18 Score on a scale
Standard Deviation 7.054
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Symptoms on waking in morning (Day 7)
8.69 Score on a scale
Standard Deviation 6.701
12.00 Score on a scale
Standard Deviation 5.673
5.45 Score on a scale
Standard Deviation 4.228
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Symptoms on waking in morning (Day 14)
8.31 Score on a scale
Standard Deviation 5.936
10.42 Score on a scale
Standard Deviation 6.543
5.00 Score on a scale
Standard Deviation 4.472
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Practical problems (Day 7)
3.00 Score on a scale
Standard Deviation 5.033
4.67 Score on a scale
Standard Deviation 3.601
2.55 Score on a scale
Standard Deviation 3.503
Change From Baseline in Mean Average Score of NRQLQ for Each Domain (Sleep, Sleep Time, Symptoms on Waking in the Morning, and Practical Problems) on the) at Day 7 and Day 14 in Participants With the Risk of Sleep Apnea.
Practical Problems (Day 14)
2.54 Score on a scale
Standard Deviation 4.858
3.08 Score on a scale
Standard Deviation 3.059
2.64 Score on a scale
Standard Deviation 2.942

SECONDARY outcome

Timeframe: At Day 7 and Day 14

Participants scored all two domains of NRQLQ using same 7 points scale: 0=Not troubled, 1=Hardly troubled, 3=moderately troubled, 4=quite a bit troubled, 5=very troubled, 6=extremely troubled. Domains were Sleep problems (difficulty getting sleep, unable to get a good night sleep or wake up during the night, restless \[tossing and turning\] and having to get up because stuffy nose or to blow nose using the score), and Symptoms on waking in the morning (Feel tired and unrefreshed, nasal congestion or stuffy nose, congestion in sinuses, takes time to clear nighttime drainage after waking up); Lower scores indicate improvement in the rhinitis symptoms.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All sleep problems (Day 7)
14 Participants
5 Participants
11 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All sleep problems (Day 14)
12 Participants
10 Participants
13 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any sleep problems (Day 7)
18 Participants
18 Participants
19 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any sleep problems (Day 14)
20 Participants
19 Participants
17 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All symptoms on waking (Day 7)
14 Participants
11 Participants
14 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
All symptoms on waking (Day 14)
14 Participants
11 Participants
16 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any symptoms on waking (Day 7)
19 Participants
17 Participants
19 Participants
Number of Participants Showing Improvement for Sleep Problems and Symptoms on Waking in the Morning Domain of the NRQLQ
Any symptoms on waking (Day 14)
19 Participants
18 Participants
19 Participants

SECONDARY outcome

Timeframe: on first night (Night 1) of each daily diary question

Population: Analysis for this outcome was performed on intent-to-treat (ITT) population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked Q2 (How stuffed does your nose feel at this time?) and Q4 (How Breathing felt after the nasal strip was applied) of daily diary questions. Q2 was scored on 4 point scale where 0=no symptoms, 1=mild symptoms, 2=moderate symptoms, 3=severe symptoms and Q4 on 11 point scale where -5=much worse, 0=same, 5=much better.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Number of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)
Q2
13 Participants
3 Participants
10 Participants
Number of Participants Showing Improvement for Daily Diary Questions (Q2 and Q4)
Q4
18 Participants
11 Participants
12 Participants

SECONDARY outcome

Timeframe: on first night (Night 1) of each daily diary question

Population: Analysis for this outcome was performed on ITT population, defined as all participants who were randomized and had at least one post-baseline efficacy assessment.

Participants were asked following daily diary VAS scale questions a) How easy it was to breathe through your nose and b) How open their nose feels at this time. Both of these questions were scored using 100 mm VAS scale where, 0=extremely difficult, 100=extremely easy.

Outcome measures

Outcome measures
Measure
Marketed Nasal Strip
n=20 Participants
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=20 Participants
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Strip
n=19 Participants
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Number of Participants Showing Improvement for VAS Scale Daily Diary Questions
Easy to breathe
20 Participants
11 Participants
15 Participants
Number of Participants Showing Improvement for VAS Scale Daily Diary Questions
Openness
19 Participants
13 Participants
13 Participants

Adverse Events

Marketed Nasal Strip

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo Nasal Strip

Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths

Prototype Nasal Dilator

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Other adverse events
Measure
Marketed Nasal Strip
n=20 participants at risk
Participants applied the Marketed nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Placebo Nasal Strip
n=21 participants at risk
Participants applied the Placebo nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
Prototype Nasal Dilator
n=19 participants at risk
Participants applied the Prototype nasal strips according to written instructions. A member of the site staff reviewed the instructions for administration with each participant. Strips were applied every night during the treatment phase of the study. All treatments in this study were self-administered by the participant.
General disorders
Nasal scab secondary to strip removal
0.00%
0/20
4.8%
1/21
0.00%
0/19

Additional Information

GSK Response Center

GlaxoSmithKline

Phone: 866-435-7343

Results disclosure agreements

  • Principal investigator is a sponsor employee GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial.
  • Publication restrictions are in place

Restriction type: OTHER